218 A case of Toxic Epidermal Necrolysis secondary to combination Ipilimumab and Nivolumab therapy for Pleural Mesothelioma, successfully treated with Ruxolitinib

We present the case of a patient who developed Toxic Epidermal Necrolysis (TEN) as the primary feature of a multi-system autoimmune syndrome following combination ipilimumab and nivolumab for mesothelioma, successfully treated with Ruxolitinib.

Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Judy Tabbakh, Racha Kussaibati, Francesca Kinsella, Gary Middleton, Victoria Kunene, Sawsan Elsheikh, Claudia Roberts, Darren Lewis, Rachel Powell, Ser-Ling Chua, Shobhit Baijal Tags: Case Reports Source Type: research